GTX12248 Lipoteichoic Acid (LTA) antibody

See related secondary antibodies

Search for all "Lipoteichoic Acid (LTA)"

0.5 mg / €310.00

Quick Overview

Mouse anti Lipoteichoic Acid (LTA) 96-110


Product Description for Lipoteichoic Acid (LTA)

Mouse anti Lipoteichoic Acid (LTA) 96-110.
Presentation: Purified
Product is tested for Enzyme Immunoassay.

Properties for Lipoteichoic Acid (LTA)

Product Category Primary Antibodies
Quantity 0.5 mg
Presentation Purified
Applications E
Clonality Monoclonal
Clone 96-110
Host Mouse
Isotype IgG1
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer GeneTex Inc.

Datasheet Extract

Staphylococcus epidermidis, Hay strain (ATCC #55133).
Isotype control AM03095PU-N
Application ELISA
Background Lipoteichoic Acid is the major proinflammatory structure present within the cell wall layer of most gram-positive bacteria. It plays an important role in the initiation and progression of bacterial infection, inflammation, and septic shock. It induces several cytokines in vivo, and Lipoteichoic Acid and peptidoglycan (PepG) synergize to cause the induction of nitric oxide formation which can lead to multiple organ failure. Since Lipoteichoic Acid is also found in the cell walls of non-pathogenic gram-positive bacteria, it has been suggested that its structure and its ability to synergize with PepG determine the ability of a particular bacterium to cause septic shock.
Concentration 1.2 mg/ml
Storage Keep as concentrated solution. Store at 4
Protein G affinity purified
Buffer System:
Phosphate-buffered saline, pH 7.4
Protein G affinity purified
Clinical strains of Staphylococcus epidermidis (types I, II, and III) and Staphylococcus aureus strains 5 and 8. Does not react with peptidoglycan of Staphylococcus aureus or peptidoglycanrhamnose, nor does it react with pneumococcal polysaccharides. This antibody does not cross-react with E. coli or H. influenzae type B. Not yet tested in other species

Accessory Products

  • LinkedIn